| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.088 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.073 | 0.6 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |